Étiquette : Publication
-
Advanced BioDesign Announces Publication in HemaSphere Uncovering Novel Mechanism Driving Chemoresistance in Acute Myeloid Leukemia
Lyon, France – November 6th, 2025 – Advanced BioDesign, a French clinical-stage biotechnology company focused on developing innovative therapies for treatment-resistant cancers, today announced the publication of its latest research in HemaSphere, the official journal of the European Hematology Association. The article, titled “Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute…
-
Advanced BioDesign Publishes Groundbreaking Study in Cell Chemical Biology Introducing ABD-0171, a Next-Generation ALDH1 Inhibitor for Resistant Solid Tumors
Lyon, France – October 1st, 2025 – – Advanced BioDesign, a biotechnology company pioneering innovative cancer therapies through the inhibition of the aldehyde dehydrogenase, today announced the publication of a landmark study in Cell Chemical Biology presenting ABD-0171, its second-generation inhibitor targeting ALDH1A3, a key enzyme implicated in cancer stemness and therapeutic resistance. The study…